Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Immune activation is a hallmark of disease progression in human immunodeficiency virus (HIV) type 1 (HIV-1) and HIV type 2 (HIV-2) infection. However, the relationship between viremia and systemic immune activation is unclear. We assessed the relationship between HIV-2 plasma virus load and immune system activation in a cross-sectional study in a community cohort of HIV-1-positive, HIV-2-positive, and HIV-negative patients, in which many HIV-2-positive patients had nonprogressing infection. HLA-DR and CD38 expression on CD4(+) and CD8(+) T cells was measured, as were plasma beta(2)-microglobulin levels. These markers were related to clinical (virus load and CD4(+) cell count) and immunological (HIV-2-specific interferon gamma secretion) correlates of delayed disease progression. A consistent positive correlation was identified between the level of HIV-2 viremia and immune activation. We propose that increasing virus load may contribute to systemic immune activation in HIV-2 infection.

Original publication

DOI

10.1086/648733

Type

Journal article

Journal

J Infect Dis

Publication Date

01/01/2010

Volume

201

Pages

114 - 122

Keywords

ADP-ribosyl Cyclase 1, Biomarkers, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Cross-Sectional Studies, Disease Progression, HIV Infections, HIV-1, HIV-2, HLA-DR Antigens, Humans, Viral Load, Viremia